Nacrez (Desogestrel)

Desogestrel binds selectively to progesterone receptors in the hypothalamus and pituitary, inhibiting the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus and alters the endometrial lining, making it less receptive to implantation, thereby delivering effective contraception.

The dosing regimen for Nacrez is determined by the prescribing clinician. Typically, it is taken as one oral tablet daily at the same time each day, but the exact strength, timing, and duration are individualized based on the patient’s medical profile.

Nacrez is not intended for use during pregnancy and should be discontinued if pregnancy occurs. Safety data for breastfeeding are limited; clinicians usually advise caution and may recommend alternative contraception for nursing mothers, weighing potential risks and benefits.

To order Nacrez, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nacrez offers a progestogen‑only option, which is advantageous for women who cannot use estrogen‑containing pills due to contraindications such as migraine with aura or thrombotic risk. Compared with combined oral contraceptives, it may have a slightly higher rate of breakthrough bleeding but carries a lower risk of estrogen‑related side effects.

Nacrez tablets should be stored at ambient temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Nacrez is taken orally, usually as a single tablet each day. Patients should swallow the tablet whole with water and aim to take it at the same time each day to maintain consistent hormone levels and maximize contraceptive effectiveness.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions, liver dysfunction, and significant hypertension. Patients should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe abdominal pain, jaundice, or signs of an allergic reaction.

Nacrez is contraindicated in women with known or suspected pregnancy, active liver disease, unexplained vaginal bleeding, or a history of thromboembolic disorders. It should also be avoided in individuals with hypersensitivity to desogestrel or any of the tablet’s excipients.